Table 1.
Subjects selected for the project
Groups | Placebo | Ca-only | Ca + D | Total | P | |
---|---|---|---|---|---|---|
Initial subjects | 288 | 445 | 446 | 1179 | ||
Exclusion | Not finished | 44 | 54 | 58 | 155 | 0.46 |
Metal prostheses/implants | 36 | 60 | 52 | 148 | 0.71 | |
Cancer | 20 | 17 | 13 | 50 | 0.03 | |
Total excluded subjects | 82 | 117 | 110 | 309 | 0.52 | |
Applied subjects | 206 | 328 | 336 | 870 | 0.52 |
Note: There were some overlaps between different exclusion criteria.
Not finished: subjects who did not finished the 4-year trial; Metal prostheses/implants: subjects with prosthetics or pacemakers implants; Cancer: subjects suffering from cancer during the 4-year trial.
P values were calculated by χ2 test to compare the difference of ineligible subjects among the three groups.